Annals of Behavioral Medicine

, Volume 27, Issue 2, pp 117–124 | Cite as

Psychological and cognitive function: Predictors of adherence with cholesterol lowering treatment

  • Carol S. Stilley
  • Susan Sereika
  • Matthew F. Muldoon
  • Christopher M. Ryan
  • Jacqueline Dunbar-Jacob

Abstract

Background: Failure to adhere to medication regimes is a significant problem in clinical and research settings yet reliable, consistent identification of key psychosocial predictors remains elusive. Studies of mood and personality related to adherence show mixed results—compliance and objectively measured cognitive function are intuitively related but empirical support is lacking.Purpose: This study is a secondary analysis to examine the relations between adherence with a medication regime for lowering serum cholesterol and several domains of psychological and cognitive functioning.Methods: Participants in the initial study completed a measure of personality and a battery of neuropsychological measures at baseline; anxiety and depression were measured at baseline and at 4-week intervals. Medication adherence was tracked with electronic cap monitors for 24 weeks.Results: Only 23% of the sample was fully adherent to medication regimes at least 80% of the time over the 6-month study period. Conscientiousness, according to the Five Factor Theory of Personality, and estimated IQ remained robust predictors of adherence in hierarchical regression analyses. Depression and anxiety, mental flexibility, and visuospatial-constructional ability were less robust but statistically significant (p < .05) correlates of adherence.Conclusions: Although results of this analysis explain only a portion of the variance in adherence, they demonstrate the importance of trait psychological and cognitive factors in adherence research.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. (1).
    Dunbar-Jacob J, Sereika S, Rohay JM, Burke LE, Kwoh CK:Predictors of adherence: Differences by measurement method. 16th Annual Scientific Sessions of the Society of Behavioral Medicine. San Diego, CA: 1995.Google Scholar
  2. (2).
    Dunbar-Jacob JM, Mortimer-Stephens MK: Treatment adherence in chronic disease.Journal of Clinical Epidemiology. 2001,54:S57-S60.PubMedCrossRefGoogle Scholar
  3. (3).
    Muldoon MF, Ryan CM, Matthews KA, Manuck SB: Serum cholesterol and intellectual performance.Psychosomatic Medicine. 1997,59:382–387.PubMedGoogle Scholar
  4. (4).
    Muldoon MF, Ryan CM, Flory JD, Matthews KA, Manuck SB: Effects of Lovastatin on cognitive functioning.American Journal of Medicine. 2000,108:538–546.PubMedCrossRefGoogle Scholar
  5. (5).
    DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: Meta-analy-sis of the effects of anxiety and depression on patient adher-ence.Archives of Internal Medicine. 2000,160:2101–2107.PubMedCrossRefGoogle Scholar
  6. (6).
    Malassiotis A, Nahas-Lopez V, Chung WY, et al.: Factors associated with adherence to antiretroviral medication in HIV-in-fected patients.International Journal of STD & AIDS. 2002,13:301–310.CrossRefGoogle Scholar
  7. (7).
    Wang PS, Bohn RL, Knight E, et al.: Noncompliance with antihypertensive medications: The impact of depressive symptoms and psychosocial factors.Journal of General Internal Medicine. 2002,17:504–511.PubMedCrossRefGoogle Scholar
  8. (8).
    Ciechanowski PS, Katon WJ, Russo JE: Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs.Archives of Internal Medicine. 2000,160:3278–3285.PubMedCrossRefGoogle Scholar
  9. (9).
    Mawhinney H, Spector SL, Heitjan D, et al.: As-needed medication use in asthma usage patterns and patient characteristics.Journal of Asthma. 1993,30:61–71.PubMedCrossRefGoogle Scholar
  10. (10).
    Christensen AJ, Ehlers SL, Wiebe JS, et al.: Patient personality and mortality: A 4-year prospective examination of chronic renal insufficiency.Health Psychology. 2002,21:315–320.PubMedCrossRefGoogle Scholar
  11. (11).
    Christensen AJ, Smith TW: Personality and patient adherence: Correlates of the five-factor model in renal dialysis.Journal of Behavioral Medicine. 1995,18:305–313.PubMedCrossRefGoogle Scholar
  12. (12).
    Christensen AJ, Moran PJ, Wiebe JS: Assessment of irrational health beliefs: Relation to health practices and medical regimen adherence.Health Psychology. 1999,18:169–176.PubMedCrossRefGoogle Scholar
  13. (13).
    Isaac IM, Tamblyn RM: Compliance and cognitive function: A methodological approach to measuring unintentional errors in medication compliance in the elderly (McGill-Calgary Drug Research Team).Gerontologist. 1993,33:772–781.PubMedGoogle Scholar
  14. (14).
    Park DC, Hertzog C, Leventhal H, et al.: Medication adherence in rheumatoid arthritis: Older is wiser.Journal of the American Geriatric Society. 1999,47:172–183.Google Scholar
  15. (15).
    Dunbar-Jacob J, Burke LE, Rohay JM, et al.: Comparability of self-report, pill count, and electronically monitored adherence data.Controlled Clinical Trials. 1996,17(25): 80S.CrossRefGoogle Scholar
  16. (16).
    Hamilton M: A rating scale for depression.Journal of Neurology, Neurosurgery and Psychiatry. 1960,23:56–62.CrossRefGoogle Scholar
  17. (17).
    Spielberger CD:Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press, 1983.Google Scholar
  18. (18).
    Costa PT, McCrae RR:NEO-PI-R Professional Manual. Odessa, FL: Psychological Assessment Resources, 1992.Google Scholar
  19. (19).
    Sattler JM:Assessment of Children (3rd ed.). San Diego, CA: Sattler, 1988.Google Scholar
  20. (20).
    Wechsler D:Wechsler Adult Intelligence Scale (3rd ed.). New York: Psychological Corporation, 1997.Google Scholar
  21. (21).
    Jarvis PE, Barth JT:The Halstead-Reitan Neuropsychological Battery: A Guide to Interpretation and Clinical Applications. Odessa, FL: Psychological Assessment Resources, 1994.Google Scholar
  22. (22).
    Reitan RM, Wolfson D:The Halstead-Reitan Neuropsychological Test Battery. Tucson, AZ: Neurospsychology Press, 1988.Google Scholar
  23. (23).
    Spreen O, Strauss E (eds):A Compendium of Neuropsychological Tests (2nd ed). New York: Oxford University Press, 1988.Google Scholar
  24. (24).
    Pilkonis PA, Frank E: Personality pathology in recurrent depression: Nature, prevalence and relationship to treatment response.American Journal of Psychiatry. 1988,145:435–441.PubMedGoogle Scholar
  25. (25).
    Zanarini MC, Frankenburg FR, Dubo ED, et al.: Axis I comorbidity of borderline personality disorder.American Journal of Psychiatry. 1998,155:1733–1739.PubMedGoogle Scholar
  26. (26).
    Cleveland BL, Denier CA: Recommendations for health care professionals to improve compliance and treatment outcome among patients with cognitive deficits.Issues in Mental Health Nursing. 1998,19:113–124.CrossRefGoogle Scholar
  27. (27).
    Bartlett JA: Addressing the challenges of adherence.Journal of Acquired Immune Deficiency Syndromes. 2002,29(S1):S2–10.Google Scholar
  28. (28).
    Dunbar-Jacob JM, Schlenk EA, Burke LE, Matthews JT: Predictors of patient adherence: Patient characteristics. In Schumaker SA, Schron EB, Ockene JK, McBee WL (eds),The Handbook of Health Behavior Change (2nd ed). New York: Springer, 1998, 491–511.Google Scholar
  29. (29).
    Christensen AJ: Patient by treatment context interaction in chronic disease: A conceptual framework for the study of patient adherence.Psychosomatic Medicine. 2000,62:435–443.PubMedGoogle Scholar

Copyright information

© The Society of Behavioral Medicine 2004

Authors and Affiliations

  • Carol S. Stilley
    • 1
    • 2
  • Susan Sereika
    • 1
  • Matthew F. Muldoon
    • 2
  • Christopher M. Ryan
    • 3
  • Jacqueline Dunbar-Jacob
    • 1
  1. 1.School of NursingUniversity of PittsburghUSA
  2. 2.Department of Psychiatry, School of MedicineUniversity of PittsburghUSA
  3. 3.Department of Psychiatry, School of MedicineUniversity of PittsburghUSA
  4. 4.Pittsburgh

Personalised recommendations